Trombolitik ve ard�ndan trombektomi uygulanan 16 ya��nda bir olgu

http://www.journalagent.com/images/submit_tur.png

Trombolitik ve ard�ndan trombektomi uygulanan 16 ya��nda bir olgu [T�rk Beyin Damar Hast Derg]

T�rk Beyin Damar Hast Derg. Kabul edilen makaleler: TBDHD-27880 | DOI: 10.5505/tbdhd.2018.27880

Trombolitik ve ard�ndan trombektomi uygulanan 16 ya��nda bir olgu

Cemile Haki¹, Atilla �zcan �zdemir², �zlem Ayka�², Ayg�l G�ne�¹, Asuman Ali¹, Damla �zyurtlu¹, Meral Sefero�lu¹
¹Sa�l�k Bilimleri �niversitesi Bursa Y�ksek �htisas E�itim ve Ara�t�rma Hastanesi, N�roloji Klini�i, Bursa
²Osmangazi �niversitesi T�p Fak�ltesi N�roloji Klini�i, Eski�ehir

Pediatrik inme insidans� y�lda her 100 000 �ocuk i�in 2.5-13.0'd�r. Akut iskemik inme ge�iren yeti�kinlerde uygun hastalarda intraven�z(i.v.) trombolitik ve trombektomi kullan�m� standart bir uygulamad�r. Bununla birlikte, pediyatrik hastalarda i.v. trombolitik tedavi ve trombektomi uygulamas� konusunda hen�z randomize bir �al��ma yoktur. Acil servise afazi ve sa� taraf�nda g��s�zl�k �ikayeti ile semptom ba�lang�c�ndan yirmi dakika sonra ba�vuran ve alteplaz uygulamas� sonras�nda klinik tablosunda d�zelme olmamas� �zerine trombektomi uygulanan ve sekel kalmayan 16 ya��nda erkek hastay� sunmay� ama�lad�k. �nme, �ocukluk ya� grubunda mortalitenin ilk on nedeninden biri olmas�na ra�men, alteplaz�n uygulanmas�nda bir�ok engel bulunmaktad�r. Pediatrik ya� grubunda i.v. trombolitik tedavi ve trombektomi uygulamas� konusunda randomize �al��ma yoktur. �ocuklarda trombolitik tedavi ve trombektominin etkinlik ve g�venilirli�ini de�erlendirecek �al��malara ihtiya� vard�r.

Anahtar Kelimeler: �nme, �ocukluk d�nemi, acil tedavi

A 16-year-old case with thrombolytic and later thrombectomy

Cemile Haki¹, Atilla �zcan �zdemir², �zlem Ayka�², Ayg�l G�ne�¹, Asuman Ali¹, Damla �zyurtlu¹, Meral Sefero�lu¹
¹Department Of Neurology Bursa Yuksek Iht�sas Tra�n�ng And Research Hosp�tal, Bursa,Turkey
²Department Of Neurology, Faculty Of Medicine, Osmangazi University, Eski�ehir

The incidence of pediatric stroke is 2.5 to 13.0 per 100,000 children per year. In adults appropriate patients with acute ischemic stroke with intravenous(i.v.) thrombolytic and thrombectomy use is a standard practice. However, in pediatric patients on i.v. thrombolytic therapy and thrombectomy there is no randomized trial. We aimed to present a 16-year-old male patient who admitted to emergency room twenty minutes after the onset of symptoms with aphasia and weakness on the right side and who underwent thrombectomy and did not have any sequelae after the application of alteplase. Although stroke is one of the first ten causes of mortality in childhood, there are many obstacles to the implementation of alteplase. �n pediatric age group there is no randomised study on i.v. thrombolytic therapy and thrombectomy. Studies are needed to evaluate the efficacy and safety of thrombolytic therapy and thrombectomy in children.

Keywords: Stroke, childhood, emergency treatment

Sorumlu Yazar: Cemile Haki, T�rkiye

ARA�LAR